Slava Epstein - iCHIP

Uncharted territory: iCHIP’s potential to generate high-throughput antibiotic production

Earlier this year, a promising antibiotic named teixobactin with the ability to vanquish drug-resistant pathogen was discovered. Early results show teixobactin to be active against the deadly bacterium MRSA (methicillin-resistant Staphylococcus aureus) in mice. This important discovery was made possible by the work Slava Epstein and his lab, who developed the iCHIP technology. Story originally posted by Nature. Follow this link to view the original …